Similar modifier gene effects have been described in other primary immunodeficiencies, such as DOCK8 deficiency and STAT1 GOF mutations, where additional genetic variants contribute to phenotypic variability and disease severity. This evidence concerns the gene STAT1 and hyperinsulinemic hypoglycemia, familial, 4.